Chintan V Shah

Chintan V Shah, M.D.

Clinical Assistant Professor

Business Phone: (352) 273-8821

About Chintan V Shah

Witnessing my father practice medicine in a medically underserved area inspired my route into medicine. As an assistant professor of medicine in the University of Florida Division of Nephrology, Hypertension and Renal Transplantation, I strive to help my patients obtain the best care. I focus on treating cancer patients with kidney disease. Oncology–nephrology is an emerging exciting field in medicine. This medical sub-specialty is quite rewarding as it is challenging and complex.

I received my Bachelor of Medicine and Surgery in India from Medical College of Baroda. Then, I completed an internal medicine residency at Cleveland Clinic/Fairview Hospital. Afterward, I completed a nephrology fellowship at Wayne State University in 2015.

I am board-certified in internal medicine and nephrology by the American Board of Internal Medicine. I have several research publications on related kidney topics. In my current role at UF, my excellence in teaching in an inpatient setting was recognized by the UF Division of Nephrology, Hypertension and Renal Transplantation, where I received an appreciation certification.

When not practicing at UF Health Nephrology – Shands Hospital, I enjoy staying active by running, scuba diving and playing tennis.

Teaching Profile

Courses Taught
PAS5010 Intro to Medicine 1

Board Certifications

  • Internal Medicine
    American Board of Internal Medicine
  • Nephrology
    American Board of Internal Medicine

Clinical Profile

  • Nephrology

Research Profile

Areas of Interest
  • chronic kidney disease


Role of leukapheresis in the management of acute kidney injury associated with hyperleukocytosis of acute myeloid leukemia.
Clinical kidney journal. 17(1) [DOI] 10.1093/ckj/sfad284. [PMID] 38213497.
Sodium-glucose cotransporter 2 inhibition, epidermal growth factor, and magnesium homeostasis: is there a link?
Kidney international. 105(3):638-639 [DOI] 10.1016/j.kint.2023.10.032. [PMID] 38388148.
Sodium/Glucose Cotransporter 2 Inhibitors and Magnesium Homeostasis.
American journal of kidney diseases : the official journal of the National Kidney Foundation. [DOI] 10.1053/j.ajkd.2023.11.006. [PMID] 38372686.
A Novel Form of Renal Tubular Acidosis Associated With Immune Checkpoint Inhibitors.
Kidney international reports. 8(1):197-201 [DOI] 10.1016/j.ekir.2022.10.019. [PMID] 36644354.
Rechallenge in Immune Checkpoint Inhibitors Associated Renal Tubular Acidosis.
Kidney international reports. 8(7):1476-1477 [DOI] 10.1016/j.ekir.2023.05.013. [PMID] 37441465.
SGLT2 Inhibitors in Management of Severe Hypomagnesemia in Patients Without Diabetes: A Report of 4 Cases.
Kidney medicine. 5(9) [DOI] 10.1016/j.xkme.2023.100697. [PMID] 37602145.
The Uncertainty Puzzle of Monoclonal Gammopathy of Renal Significance Without Detectable Clones.
Kidney international reports. 8(12):2511-2514 [DOI] 10.1016/j.ekir.2023.10.013. [PMID] 38106591.
Acute kidney injury in patients receiving pembrolizumab combination therapy versus pembrolizumab monotherapy for advanced lung cancer.
Kidney international. 102(4):930-935 [DOI] 10.1016/j.kint.2022.07.019. [PMID] 35964800.
Immune checkpoint inhibitor associated renally limited thrombotic microangiopathy – a clinical dilemma.
European journal of cancer (Oxford, England : 1990). 169:126-130 [DOI] 10.1016/j.ejca.2022.03.031. [PMID] 35561455.
Rescue Therapies for AKI in Onconephrology: Rasburicase and Glucarpidase.
Seminars in nephrology. 42(6) [DOI] 10.1016/j.semnephrol.2023.151342. [PMID] 37167817.
RNA Virus Gene Signatures Detected in Patients With Cardiomyopathy After Chemotherapy; A Pilot Study.
Frontiers in cardiovascular medicine. 9 [DOI] 10.3389/fcvm.2022.821162. [PMID] 35360008.
Shorter versus longer corticosteroid duration and recurrent immune checkpoint inhibitor-associated AKI.
Journal for immunotherapy of cancer. 10(9) [DOI] 10.1136/jitc-2022-005646. [PMID] 36137651.
Sodium-Glucose Cotransporter 2 Inhibitors and Management of Refractory Hypomagnesemia Without Overt Urinary Magnesium Wasting: A Report of 2 Cases.
Kidney medicine. 4(10) [DOI] 10.1016/j.xkme.2022.100533. [PMID] 36185705.
The Role of Kidney Biopsy in Immune Checkpoint Inhibitor-Associated AKI.
Kidney360. 3(3):530-533 [DOI] 10.34067/KID.0000232022. [PMID] 35582173.
Acute kidney injury in patients treated with immune checkpoint inhibitors.
Journal for immunotherapy of cancer. 9(10) [DOI] 10.1136/jitc-2021-003467. [PMID] 34625513.
AKI Treated with Renal Replacement Therapy in Critically Ill Patients with COVID-19.
Journal of the American Society of Nephrology : JASN. 32(1):161-176 [DOI] 10.1681/ASN.2020060897. [PMID] 33067383.
Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19.
JAMA internal medicine. 181(1):41-51 [DOI] 10.1001/jamainternmed.2020.6252. [PMID] 33080002.
Binocular Accommodation and Vergence Dysfunction in Children Attending Online Classes During the COVID-19 Pandemic: Digital Eye Strain in Kids (DESK) Study-2.
Journal of pediatric ophthalmology and strabismus. 58(4):224-231 [DOI] 10.3928/01913913-20210217-02. [PMID] 34288760.
Characteristics and Outcomes of Individuals With Pre-existing Kidney Disease and COVID-19 Admitted to Intensive Care Units in the United States.
American journal of kidney diseases : the official journal of the National Kidney Foundation. 77(2):190-203.e1 [DOI] 10.1053/j.ajkd.2020.09.003. [PMID] 32961244.
Real-world experience of carfilzomib-associated cardiovascular adverse events: SEER-Medicare data set analysis.
Cancer medicine. 10(1):70-78 [DOI] 10.1002/cam4.3568. [PMID] 33169938.
Reduction of immunosuppression for post-transplant lymphoproliferative disorder (PTLD): a single-center experience of allograft survival outcomes.
Leukemia & lymphoma. 62(5):1123-1128 [DOI] 10.1080/10428194.2020.1861266. [PMID] 33327817.
Utilization Pattern of Computed Tomographic Colonography in the United States: Analysis of the U.S. National Health Interview Survey.
Cancer prevention research (Philadelphia, Pa.). 14(1):113-122 [DOI] 10.1158/1940-6207.CAPR-20-0175. [PMID] 32938642.
Cardiovascular toxicity in patients treated with immunotherapy for metastatic non-small cell lung cancer: A SEER-medicare study: CVD outcomes with the use of ICI in mNSCLC.
Lung cancer (Amsterdam, Netherlands). 150:172-177 [DOI] 10.1016/j.lungcan.2020.10.017. [PMID] 33186859.
Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US.
JAMA internal medicine. 180(11):1436-1447 [DOI] 10.1001/jamainternmed.2020.3596. [PMID] 32667668.
Impact of DPP4 Inhibitors in Survival of Patients With Prostate, Pancreas, and Breast Cancer.
Frontiers in oncology. 10 [DOI] 10.3389/fonc.2020.00405. [PMID] 32296640.
In-hospital cardiac arrest in critically ill patients with covid-19: multicenter cohort study.
BMJ (Clinical research ed.). 371 [DOI] 10.1136/bmj.m3513. [PMID] 32998872.
Outcomes of critically ill solid organ transplant patients with COVID-19 in the United States.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 20(11):3061-3071 [DOI] 10.1111/ajt.16280. [PMID] 32844546.
Utilization of Antineoplastic Agents and Medicare Spending in Elderly Patients With Extensive-Stage Small-Cell Lung Cancer Between 2001 and 2013.
JCO oncology practice. 16(7):e610-e621 [DOI] 10.1200/JOP.19.00559. [PMID] 32074011.
A multi-center retrospective analysis of the effect of DPP4 inhibitors on progression-free survival in advanced airway and colorectal cancers.
Molecular and clinical oncology. 10(1):118-124 [DOI] 10.3892/mco.2018.1766. [PMID] 30655986.
Dipeptidyl peptidase 4 inhibitors as novel agents in improving survival in diabetic patients with colorectal cancer and lung cancer: A Surveillance Epidemiology and Endpoint Research Medicare study.
Cancer medicine. 8(8):3918-3927 [DOI] 10.1002/cam4.2278. [PMID] 31124302.
Cardiotoxicity associated with carfilzomib: systematic review and meta-analysis.
Leukemia & lymphoma. 59(11):2557-2569 [DOI] 10.1080/10428194.2018.1437269. [PMID] 29465266.
Efficacy and safety of carfilzomib in relapsed and/or refractory multiple myeloma: systematic review and meta-analysis of 14 trials.
Oncotarget. 9(34):23704-23717 [DOI] 10.18632/oncotarget.25281. [PMID] 29805768.
The role of a best practice alert in the electronic medical record in reducing repetitive lab tests.
ClinicoEconomics and outcomes research : CEOR. 10:611-618 [DOI] 10.2147/CEOR.S167499. [PMID] 30323637.
Unanticipated Cardiotoxicity Associated with Targeted Anticancer Therapy in Patients with Hematologic Malignancies Patients: Natural History and Risk Factors.
Cardiovascular toxicology. 18(2):184-191 [DOI] 10.1007/s12012-017-9429-8. [PMID] 29022233.
Survival differences among patients with hepatocellular carcinoma based on the stage of disease and therapy received: pre and post sorafenib era.
Journal of gastrointestinal oncology. 8(5):789-798 [DOI] 10.21037/jgo.2017.06.16. [PMID] 29184682.
Plasma cytokines and chemokines in primary graft dysfunction post-lung transplantation.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 9(2):389-96 [DOI] 10.1111/j.1600-6143.2008.02497.x. [PMID] 19120076.
Microsphaeropsis olivacea keratitis and consecutive endophthalmitis.
American journal of ophthalmology. 131(1):142-3 [PMID] 11162997.
Myocardial infarction in the young.
The Journal of the Association of Physicians of India. 39(7):525-6 [PMID] 1800494.
Tetralogy of Fallot with absent pulmonary valve.
The Journal of the Association of Physicians of India. 32(11):991-2 [PMID] 6526788.


Fellowship – Nephrology
2015 · Wayne State University
Residency – Internal Medicine
2013 · Cleveland Clinic – Fairview Hospital
Bachelor of Medicine and Surgery – Medicine
2009 · Medical College Baroda

Contact Details

(352) 273-8821
Business Mailing:
PO Box 100224